Annual accounts receivable:
$7.77M+$2.53M(+48.41%)Summary
- As of today (June 17, 2025), NAGE annual accounts receivable is $7.77 million, with the most recent change of +$2.53 million (+48.41%) on December 1, 2024.
- During the last 3 years, NAGE annual accounts receivable has risen by +$2.54 million (+48.64%).
- NAGE annual accounts receivable is now -8.42% below its all-time high of $8.48 million, reached on December 1, 2022.
Performance
NAGE Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$7.05M-$716.00K(-9.22%)Summary
- As of today (June 17, 2025), NAGE quarterly accounts receivable is $7.05 million, with the most recent change of -$716.00 thousand (-9.22%) on March 1, 2025.
- Over the past year, NAGE quarterly accounts receivable has increased by +$448.00 thousand (+6.78%).
- NAGE quarterly accounts receivable is now -23.52% below its all-time high of $9.22 million, reached on March 1, 2023.
Performance
NAGE Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NAGE Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.4% | +6.8% |
| 3 y3 years | +48.6% | +11.8% |
| 5 y5 years | +257.1% | +98.2% |
NAGE Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +48.6% | -23.5% | +66.8% |
| 5 y | 5-year | -8.4% | +257.1% | -23.5% | +161.8% |
| alltime | all time | -8.4% | +2125.2% | -23.5% | +1920.0% |
NAGE Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $7.05M(-9.2%) |
| Dec 2024 | $7.77M(+48.4%) | $7.77M(+9.5%) |
| Sep 2024 | - | $7.10M(-9.2%) |
| Jun 2024 | - | $7.82M(+18.4%) |
| Mar 2024 | - | $6.60M(+26.2%) |
| Dec 2023 | $5.23M(-38.3%) | $5.23M(-6.6%) |
| Sep 2023 | - | $5.60M(-8.5%) |
| Jun 2023 | - | $6.12M(-33.7%) |
| Mar 2023 | - | $9.22M(+8.7%) |
| Dec 2022 | $8.48M(+62.3%) | $8.48M(+78.8%) |
| Sep 2022 | - | $4.74M(+12.2%) |
| Jun 2022 | - | $4.23M(-33.0%) |
| Mar 2022 | - | $6.31M(+20.7%) |
| Dec 2021 | $5.23M(+94.0%) | $5.23M(-1.3%) |
| Sep 2021 | - | $5.29M(-11.7%) |
| Jun 2021 | - | $6.00M(+29.1%) |
| Mar 2021 | - | $4.65M(+72.5%) |
| Dec 2020 | $2.69M(+23.9%) | $2.69M(-16.2%) |
| Sep 2020 | - | $3.21M(-18.7%) |
| Jun 2020 | - | $3.95M(+11.1%) |
| Mar 2020 | - | $3.56M(+63.6%) |
| Dec 2019 | $2.17M(-50.1%) | $2.17M(-63.5%) |
| Sep 2019 | - | $5.95M(+3.7%) |
| Jun 2019 | - | $5.74M(+8.1%) |
| Mar 2019 | - | $5.31M(+21.8%) |
| Dec 2018 | $4.36M(-18.3%) | $4.36M(-8.7%) |
| Sep 2018 | - | $4.77M(-7.0%) |
| Jun 2018 | - | $5.13M(+7.5%) |
| Mar 2018 | - | $4.77M(-10.6%) |
| Dec 2017 | $5.34M(-8.8%) | $5.34M(+8.5%) |
| Sep 2017 | - | $4.92M(+7.4%) |
| Jun 2017 | - | $4.58M(-9.2%) |
| Mar 2017 | - | $5.04M(-13.8%) |
| Dec 2016 | $5.85M | $5.85M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $6.51M(-4.2%) |
| Jun 2016 | - | $6.79M(+56.9%) |
| Mar 2016 | - | $4.33M(+76.7%) |
| Dec 2015 | $2.45M(+28.5%) | $2.45M(-35.2%) |
| Sep 2015 | - | $3.78M(+22.1%) |
| Jun 2015 | - | $3.10M(+38.7%) |
| Mar 2015 | - | $2.23M(+17.2%) |
| Dec 2014 | $1.91M(+127.3%) | $1.91M(-24.6%) |
| Sep 2014 | - | $2.53M(+19.2%) |
| Jun 2014 | - | $2.12M(+27.2%) |
| Mar 2014 | - | $1.67M(+98.8%) |
| Dec 2013 | $838.80K(-56.8%) | $838.80K(-18.2%) |
| Sep 2013 | - | $1.03M(-13.6%) |
| Jun 2013 | - | $1.19M(+20.3%) |
| Mar 2013 | - | $986.40K(-49.2%) |
| Dec 2012 | $1.94M(+168.1%) | $1.94M(+61.3%) |
| Sep 2012 | - | $1.20M(+21.8%) |
| Jun 2012 | - | $988.20K(-29.4%) |
| Mar 2012 | - | $1.40M(+93.5%) |
| Dec 2011 | $723.70K(-27.7%) | $723.70K(+11.5%) |
| Sep 2011 | - | $648.80K(-22.9%) |
| Jun 2011 | - | $841.90K(-32.0%) |
| Mar 2011 | - | $1.24M(+23.6%) |
| Dec 2010 | $1.00M(+101.2%) | $1.00M(+71.4%) |
| Sep 2010 | - | $584.30K(-30.9%) |
| Jun 2010 | - | $845.60K(+10.0%) |
| Mar 2010 | - | $768.50K(+54.3%) |
| Dec 2009 | $497.90K(+42.6%) | $497.90K(-0.4%) |
| Sep 2009 | - | $499.70K(+19.3%) |
| Jun 2009 | - | $418.70K(-7.9%) |
| Mar 2009 | - | $454.40K(+30.2%) |
| Dec 2008 | $349.10K | $349.10K(-34.4%) |
| Sep 2008 | - | $532.40K(+5.6%) |
| Jun 2008 | - | $504.40K |
FAQ
- What is Niagen Bioscience annual accounts receivable?
- What is the all time high annual accounts receivable for Niagen Bioscience?
- What is Niagen Bioscience annual accounts receivable year-on-year change?
- What is Niagen Bioscience quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Niagen Bioscience?
- What is Niagen Bioscience quarterly accounts receivable year-on-year change?
What is Niagen Bioscience annual accounts receivable?
The current annual accounts receivable of NAGE is $7.77M
What is the all time high annual accounts receivable for Niagen Bioscience?
Niagen Bioscience all-time high annual accounts receivable is $8.48M
What is Niagen Bioscience annual accounts receivable year-on-year change?
Over the past year, NAGE annual accounts receivable has changed by +$2.53M (+48.41%)
What is Niagen Bioscience quarterly accounts receivable?
The current quarterly accounts receivable of NAGE is $7.05M
What is the all time high quarterly accounts receivable for Niagen Bioscience?
Niagen Bioscience all-time high quarterly accounts receivable is $9.22M
What is Niagen Bioscience quarterly accounts receivable year-on-year change?
Over the past year, NAGE quarterly accounts receivable has changed by +$448.00K (+6.78%)